openPR Logo
Press release

Allergic Rhinitis - US Drug Forecast And Market Analysis To 2024

09-27-2016 04:49 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Allergic Rhinitis

Summary

AR is becoming an increasingly prevalent condition, with the most common form being moderate to severe in nature (Baena-Cagnani et al., 2015). According to the European Academy of Allergy and Clinical Immunology (EAACI), 50% of Europeans will suffer from an allergy by 2027 (Papadopoulos et al., 2012). The allergic rhinitis (AR) market has declined very slowly over the past decade, as has it become saturated with relatively efficacious standard therapies, such as antihistamines (AHs), intranasal corticosteroids (INCS), and leukotriene receptor antagonists (LRAs), and has also been facing increasing generic competition. Despite the rising prevalence of AR, and a large patient population that is dissatisfied with the current treatment options, the market size for symptomatic therapies alone is set to shrink, as the remaining branded products lose patent protection. There is an increasing shift in the transfer of prescription AR products to over-the-counter (OTC) status, which is driving patients to pharmacies rather than to physicians, further diluting the prescription AR market. The immense, crowded generic AR market has been largely unappealing to drug manufacturers. Consequently, only two symptomatic therapies are expected to launch before 2024.

In 2014, the base year of the forecast period, AR sales in the US were around $2.8 billion. As in the global markets, this decrease will be fueled mainly by the patent expiries of numerous INCS, and the launch of the first OTC INCS in US pharmacies. Despite the fact that the prevalence of AR patients is set to increase over the forecast period, only one drug will be launched during this time, which is expected to face stiff competition upon entry and capture little market share.

*This is an on-demand report and will be delivered within 24 hrs. (excluding weekends) of the purchase.

Get free sample Copy at http://www.marketresearchreports.biz/sample/sample/821916

Scope

- Overview of Allergic Rhinitis including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape.
- Detailed information on the key drugs in the US including product description, safety and efficacy profiles as well as a SWOT analysis.
- Sales forecast for the top drugs in the US from 2014-2024.
- Analysis of the impact of key events as well the drivers and restraints affecting the US Allergic Rhinitis market.

Reasons to buy

- Understand and capitalize by identifying products that are most likely to ensure a robust return
- Stay ahead of the competition by understanding the changing competitive landscape for Allergic Rhinitis.
- Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential
- Make more informed business decisions from insightful and in-depth analysis of drug performance
- Obtain sales forecast for drugs from 2014-2024 in the US.

MarketResearchReports.biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-621-2074
Website: http://www.marketresearchreports.biz/
Email: sales@marketresearchreports.biz

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Allergic Rhinitis - US Drug Forecast And Market Analysis To 2024 here

News-ID: 367531 • Views:

More Releases for INCS

Peraso Inc.'s (NASDAQ: PRSO) Beamforming Technology Gains Military Traction - Se …
Peraso Inc.'s (NASDAQ: PRSO) advanced beamforming technology has proven to be a game-changer in military and dense urban deployments, where secure, reliable, and high-performance communication is critical. Beamforming's ability to direct signals with precision and bend them around obstacles not only maximizes efficiency but also makes transmissions exceptionally difficult to detect or intercept. These stealth capabilities, combined with Peraso's proprietary innovations, have enabled its solutions to excel in active war
Great Lakes Grounds Management Announces Acquisition of Evergreen Tree & Lawncar …
This carved out acquisition is the third and largest acquisition by Great Lakes Grounds Management since 2018 Image: https://www.getnews.info/uploads/76cba3c9652fb533e7f69c4b9e5271a2.png Great Lakes Grounds Management [https://www.greatlakesgroundsmanagement.com/] has announced its third and largest acquisition since 2018. In a recent carved out acquisition, Amherst, Ohio, based Great Lakes Grounds Management obtained the commercial landscape maintenance division of Evergreen Tree & Lawncare, Inc. This acquisition comes as Great Lakes Grounds Management continues to forge an expansion of its
Microphone Market Worth US$ 4.6 Billion by 2032 | Future Market Insights,Incs
The market for microphones market will have a value of about US$ 2.3 billion in 2022. It would surpass US$ 4.6 billion by 2032. The market's CAGR over the anticipated period would be 7.1%. Over the next ten years, there will be an increase in demand for hearing aids with excellent microphones. It's blamed on the escalating issue of hearing loss among the elderly. Even in a setting that is extremely complicated and busy,
Optimin, Incs CEO Abhishek Tiwari talks about the Future of AI, ChatGPT, and his …
The following is the highlights of the interview with Optimin CEO Abhishek Tiwari dicussing AI's Potential to Revolutionize Industries! MIDDLETOWN, DELAWARE, UNITED STATES: Abhishek Tiwari, CEO of Optimin, Inc, an emerging AI tech company, recently sat down for an interview. During the interview, Tiwari discussed the future of AI, his thoughts on ChatGPT, and his personal life. What Abhishek thinks about the future of AI? Tiwari began by talking about the potential of
Softura Launches New Partner Program
[Detroit, 28/06/2023] Softura, a leading outsources software development company, has announced a new Partner Program. It's designed to help channel partners to offer software development services without having to be software developers. These services include either integrations, apps, modernization or full-scale applications. "Softura can allow partners to become more full-service, while adding an entirely new revenue stream," says Mark Murphy, CEO of Softura. "Their involvement is especially valuable, since they are
Mechanical Pump Industry Is Expanding at a CAGR of 5.1% by 2031 | PumpWorks, Sul …
The global mechanical pump market was valued at US$ 49.6 billion in 2021 and it is anticipated to grow up to US$ 82.0 billion by 2031, at a CAGR of 5.1% during the forecast period. Mechanical pumps use mechanical devices such as pistons, claws, rolls, and diaphragms to create a vacuum by acting on the viscous properties of the exhausted gas or liquid. Mechanical vacuum pumps and their respective lubricants must